RBC Europe’s VanEck Biotech ETF BBH Stock Holding History

RBC Europe’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$280K	Hold	1,920	–	–	0.01%	176
2022 Q1	$311K	Hold	1,920	–	–	0.01%	187
2021 Q4	$364K	Buy	+1,920	New	+$370K	0.02%	172

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

RBC Europe's BBH Position: Q2 2022 in Review

RBC Europe held its VanEck Biotech ETF (BBH) position steady in Q2 2022 at 1,920 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #176.

RBC Europe first reported a position in BBH in Q4 2021 and has held it in 3 quarters since. The position peaked at $364K in Q4 2021. 108 funds tracked by Wall St. Rank hold BBH as of Q2 2022.

RBC Europe held 1,920 shares of VanEck Biotech ETF worth $280K as of Q2 2022.
RBC Europe left its VanEck Biotech ETF share count unchanged in Q2 2022.
VanEck Biotech ETF made up 0.01% of RBC Europe's portfolio in Q2 2022, its #176 holding.
RBC Europe first reported a position in VanEck Biotech ETF in Q4 2021 and has held it in 3 quarters since.
RBC Europe's VanEck Biotech ETF position peaked at $364K in Q4 2021.
108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.